Literature DB >> 13870119

Diabetes mellitus and cirrhosis of the liver.

J M BLOODWORTH.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/statistics; LIVER CIRRHOSIS/statistics

Mesh：

Year:  1961        PMID： 13870119     DOI： 10.1001/archinte.1961.03620110035006

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  8 in total

1.  Development of diabetes mellitus after portacaval anastomosis.

Authors:  G W HEARN; A PATON
Journal:  Br Med J       Date:  1963-07-13

Review 2.  [The pathogenesis of hepatogenic diabetes mellitus].

Authors:  K Kopetz
Journal:  Klin Wochenschr       Date:  1970-11-01

3.  [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].

Authors:  K Kopetz; P Wehrmann
Journal:  Klin Wochenschr       Date:  1970-11-01

4.  [The incidence of liver cirrhosis in diabetes mellitus].

Authors:  J Rostlapil; M Zrůstová
Journal:  Acta Diabetol Lat       Date:  1969 Jan-Mar

5.  [The significance of diabetes mellitus in the indications for portacaval anastomosis in portal hypertension of liver cirrhosis].

Authors:  G Esser; H W Schreiber
Journal:  Langenbecks Arch Chir       Date:  1965-09-28

6.  Cirrhosis and diabetes. I. Increased incidence of diabetes in patients with Laennec's cirrhosis.

Authors:  H O Conn; W Schreiber; S G Elkington; T R Johnson
Journal:  Am J Dig Dis       Date:  1969-12

7.  Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis.

Authors:  Felix I Tellez-Avila; Francisco Sanchez-Avila; Mauricio García-Saenz-de-Sicilia; Norberto C Chavez-Tapia; Ada M Franco-Guzman; Gustavo Lopez-Arce; Eduardo Cerda-Contreras; Misael Uribe
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

Review 8.  From the origin of NASH to the future of metabolic fatty liver disease.

Authors:  Andreas Geier; Dina Tiniakos; Helmut Denk; Michael Trauner
Journal:  Gut       Date:  2021-02-25       Impact factor: 23.059
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.